Evidence map›Paper›PMID 28212568›Full record

ArticleOncotarget2017

An anthocyanin rich strawberry extract induces apoptosis and ROS while decreases glycolysis and fibrosis in human uterine leiomyoma cells.

Md Soriful Islam, Francesca Giampieri, Milijana Janjusevic, Massimiliano Gasparrini, Tamara Y Forbes-Hernandez, Luca Mazzoni, Stefania Greco, Stefano Raffaele Giannubilo, Andrea Ciavattini, Bruno Mezzetti and 4 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Uterine Fibroids and Diet.International journal of environmental research and public health · 2021
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Essential role of the NaScientific reports · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Md Soriful IslamDepartment of Experimental and Clinical Medicine, Università Politecnica delle Marche, Ancona, Italy.
Francesca GiampieriDepartment of Clinical Science, Università Politecnica delle Marche, Ancona, Italy.
Milijana JanjusevicDepartment of Experimental and Clinical Medicine, Università Politecnica delle Marche, Ancona, Italy.
Massimiliano GasparriniDepartment of Clinical Science, Università Politecnica delle Marche, Ancona, Italy.
Tamara Y Forbes-HernandezDepartment of Clinical Science, Università Politecnica delle Marche, Ancona, Italy.
Luca MazzoniDepartment of Clinical Science, Università Politecnica delle Marche, Ancona, Italy.
Stefania GrecoDepartment of Experimental and Clinical Medicine, Università Politecnica delle Marche, Ancona, Italy.
Stefano Raffaele GiannubiloDepartment of Clinical Science, Università Politecnica delle Marche, Ancona, Italy.
Andrea CiavattiniDepartment of Clinical Science, Università Politecnica delle Marche, Ancona, Italy.
Bruno MezzettiDepartment of Agricultural, Food and Environmental Sciences, Università Politecnica delle Marche, Ancona, Italy.
Franco CapocasaDepartment of Agricultural, Food and Environmental Sciences, Università Politecnica delle Marche, Ancona, Italy.
Mario CastellucciDepartment of Experimental and Clinical Medicine, Università Politecnica delle Marche, Ancona, Italy.
Maurizio BattinoDepartment of Clinical Science, Università Politecnica delle Marche, Ancona, Italy.
Pasquapina CiarmelaDepartment of Experimental and Clinical Medicine, Università Politecnica delle Marche, Ancona, Italy.
Marche Polytechnic University · ITUniversity of Rajshahi · BD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Uterine leiomyomas are highly prevalent benign tumors in reproductive aged women. Unfortunately, medical treatments are still limited and no preventive therapies have been developed. In the present study, we investigated the therapeutic effects of strawberry extract on uterine leiomyoma cells. Leiomyoma and myometrial cells were treated with strawberry (cultivar Alba) extract (250 μg/ml) for 48 h to measure apoptosis, reactive oxygen species (ROS), oxidative phosphorylation (OCR, oxygen consumption rate) and glycolysis (ECAR, extracellular acidification rate) as well as fibrosis associated gene and/or protein expression. In leiomyoma cells, strawberry increased the percentage of apoptotic and dead cells. Strawberry significantly increased ROS concentration in leiomyoma cells, while decreased it in myometrial cells. After strawberry treatment, leiomyoma cells showed a significant decreased rate of ECAR, while OCR was unchanged in both myometrial and leiomyoma cells. Strawberry significantly decreased collagen1A1, fibronectin and versican mRNA expression in leiomyoma cells. The reduced protein expression of fibronectin was observed by strawberry extract in leiomyoma cells as well. Furthermore, strawberry was able to reduce activin A induced fibronectin, collagen1A1, and versican as well as activin A and PAI-1 mRNA expression in leiomyoma cells. This study suggests that strawberry can be developed as therapeutic and/or preventive agent for uterine leiomyomas.

Indexed as

ActivinsAnthocyaninsApoptosisBlotting, WesternCell SurvivalCollagen Type ICollagen Type I, alpha 1 ChainFemaleFibrosisFragariaGene Expression Regulation, NeoplasticGlycolysisHumansLeiomyomaOxidative PhosphorylationOxygen Consumptionactivin AActivinsAnthocyaninsCollagen Type ICollagen Type I, alpha 1 ChainPlant ExtractsPlasminogen Activator Inhibitor 1Reactive Oxygen SpeciesVersicansapoptosisfibrosisROSstrawberryuterine leiomyoma

Identifiers

PMID28212568
PMCPMC5410328
OpenAlexW2587972672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.